Previous PostRelmada Therapeutics Strengthens Board of Directors with Appointment of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool
Next PostiView Announces First Patient Treated in Phase 2 Clinical Trial Program Evaluating IVIEW-1201 in Patients with Acute Adenoviral Conjunctivitis